Recurrent and new primary cancer risk in adult patients with idiopathic inflammatory myositis and a history of malignancy
In our tertiary referral centre, approximately one quarter of adult IIM patients who had a cancer diagnosis in the three years before IIM onset went on to develop an additional malignancy, either a recurrence or a new primary.
Authors
- J. Paik
- Brit L. Adler
- XingYao Wang (ORCID: https://orcid.org/0000-0001-9993-8864)
- Eleni Tiniakou
- Christopher A. Mecoli
- Jemima Albayda
- Andrew L. Mammen
- Lisa Christopher-Stine
- Livia Casciola-Rosen
Institutions
- Johns Hopkins University (US)
- Johns Hopkins Medicine (US)
- National Institute of Arthritis and Musculoskeletal and Skin Diseases (US)
Publication Details
- Journal
- Clinical and Experimental Rheumatology
- Published
- 2026-02-24
- DOI
- https://doi.org/10.55563/clinexprheumatol/dlho6a
- Primary Topic
- Inflammatory Myopathies and Dermatomyositis
- Type
- article
- Field-Weighted Citation Impact
- 0.00
Funders
- Johns Hopkins University
- Jerome L. Greene Foundation
- National Institutes of Health